S&P 500

5.222,68

0,16%

Aumente o nível de sua negociação com nossas ferramentas poderosas e insights em tempo real, tudo em um só lugar.

Cadastre-se

Início
Investir
Ações
EUA
AMEX
Palatin Technologies Inc New (PTN)
Palatin Technologies Inc New (PTN) Notícias

PTN

Palatin Technologies (PTN)

Palatin Technologies Inc New

De:

Notícias regulamentadas

Procure um Texto:

Ordenação:

Notícias não regulamentadas

Apresentando as notícias mais relevantes sobre:AMEX:PTN

1 2 3 4 5 6 7 8 9 Próxima >>

Data	Hora	Fonte	Título	Código	Companhia
09/05/2024	08:30	PR Newswire (US)	Palatin to Report Third Quarter Fiscal Year 2024 Results; Teleconference and Webcast to be held on May 15, 2024	AMEX:PTN	Palatin Technologies Inc New
02/05/2024	08:30	PR Newswire (US)	Palatin Announces FDA Clearance of IND Application for the Co-Administration of Bremelanotide with Tirzepatide (GLP-1) for the Treatment of Obesity	AMEX:PTN	Palatin Technologies Inc New
30/04/2024	08:30	PR Newswire (US)	Palatin to Host Virtual KOL Event "Beyond GLPs: The Multiple Roles for Novel Melanocortin Receptor 4 Agonists in Treating Obesity and Weight Loss Maintenance" on May 8, 2024	AMEX:PTN	Palatin Technologies Inc New
08/04/2024	08:30	PR Newswire (US)	Palatin Announces Phase 3 PL9643 MELODY-1 Dry Eye Disease (DED) Clinical Data Results Presented at American Society of Cataract and Refractive Surgery (ASCRS) 2024	AMEX:PTN	Palatin Technologies Inc New
07/03/2024	19:02	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	AMEX:PTN	Palatin Technologies Inc New
04/03/2024	14:57	Edgar (US Regulatory)	Form 144 - Report of proposed sale of securities	AMEX:PTN	Palatin Technologies Inc New
28/02/2024	09:30	PR Newswire (US)	Palatin Announces Results of PL9643 MELODY-1 Pivotal Phase 3 Clinical Trial in Patients with Dry Eye Disease (DED)	AMEX:PTN	Palatin Technologies Inc New
15/02/2024	11:00	Edgar (US Regulatory)	Form 8-K - Current report	AMEX:PTN	Palatin Technologies Inc New
15/02/2024	09:30	PR Newswire (US)	Palatin Reports Second Quarter Fiscal Year 2024 Financial Results and Provides Corporate Update	AMEX:PTN	Palatin Technologies Inc New
14/02/2024	18:17	Edgar (US Regulatory)	Form 10-Q - Quarterly report [Sections 13 or 15(d)]	AMEX:PTN	Palatin Technologies Inc New
14/02/2024	16:55	Edgar (US Regulatory)	Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]	AMEX:PTN	Palatin Technologies Inc New
09/02/2024	09:30	PR Newswire (US)	Palatin to Report Second Quarter Fiscal Year 2024 Results; Teleconference and Webcast to be held on February 15, 2024	AMEX:PTN	Palatin Technologies Inc New
05/02/2024	09:30	PR Newswire (US)	Palatin Announces Database Lock for PL9643 MELODY-1 Pivotal Phase 3 Clinical Trial in Patients with Dry Eye Disease (DED)	AMEX:PTN	Palatin Technologies Inc New
01/02/2024	18:00	PR Newswire (US)	Palatin Announces Closing of $10 Million Registered Direct Offering	AMEX:PTN	Palatin Technologies Inc New
01/02/2024	11:40	Edgar (US Regulatory)	Form 424B5 - Prospectus [Rule 424(b)(5)]	AMEX:PTN	Palatin Technologies Inc New
30/01/2024	10:00	PR Newswire (US)	Palatin Announces $10 Million Registered Direct Offering	AMEX:PTN	Palatin Technologies Inc New
08/01/2024	12:33	PR Newswire (US)	Palatin Provides Corporate Update and Highlights Strategic Priorities for Calendar Year 2024	AMEX:PTN	Palatin Technologies Inc New
03/01/2024	10:00	Business Wire	Cosette Pharmaceuticals Acquires Vyleesi® (Bremelanotide Injection) from Palatin Technologies Inc.	AMEX:PTN	Palatin Technologies Inc New
20/12/2023	09:30	PR Newswire (US)	Palatin Completes Sale of Vyleesi® to Cosette Pharmaceuticals for up to $171 Million	AMEX:PTN	Palatin Technologies Inc New
18/12/2023	18:15	PR Newswire (US)	Palatin Receives Notice of Acceptance of the Listing Standards Compliance Plan from NYSE American	AMEX:PTN	Palatin Technologies Inc New
18/12/2023	02:15	Edgar (US Regulatory)	Form EFFECT - Notice of Effectiveness	AMEX:PTN	Palatin Technologies Inc New
15/12/2023	18:03	Edgar (US Regulatory)	Form 424B3 - Prospectus [Rule 424(b)(3)]	AMEX:PTN	Palatin Technologies Inc New
04/12/2023	19:00	Edgar (US Regulatory)	Form S-1 - General form for registration of securities under the Securities Act of 1933	AMEX:PTN	Palatin Technologies Inc New
14/11/2023	09:30	PR Newswire (US)	Palatin Reports First Quarter Fiscal Year 2024 Financial Results and Provides Corporate Update	AMEX:PTN	Palatin Technologies Inc New
09/11/2023	09:30	PR Newswire (US)	Palatin to Report First Quarter Fiscal Year 2024 Results; Teleconference and Webcast to be held on November 14, 2023	AMEX:PTN	Palatin Technologies Inc New
24/10/2023	17:50	PR Newswire (US)	Palatin Announces Closing of $5 Million Registered Direct Offering	AMEX:PTN	Palatin Technologies Inc New
23/10/2023	08:30	PR Newswire (US)	Palatin Announces $5 Million Registered Direct Offering	AMEX:PTN	Palatin Technologies Inc New
19/10/2023	08:30	PR Newswire (US)	Palatin Announces Preliminary Quarter Ended September 30, 2023 Vyleesi® Product Revenue Results	AMEX:PTN	Palatin Technologies Inc New
18/10/2023	08:30	PR Newswire (US)	Palatin Announces Positive Preclinical Data Showing Synergistic Weight Loss; Initiating Clinical Study of Melanocortin 4 Receptor Agonist + GLP-1 in Obese Patients	AMEX:PTN	Palatin Technologies Inc New
16/10/2023	08:30	PR Newswire (US)	Palatin Presents Data at the United European Gastroenterology Week 2023 Conference On PL8177 Ulcerative Colitis Treatment	AMEX:PTN	Palatin Technologies Inc New